Status: Enacted
Year Enacted: 1981
Co-payments are permissible for most health care services, but not for chronic illness treatment. There is a $2 co-pay for generic drugs.
35 Pa. Stat. and Cons. Stat. Ann. §§ 960.1 through 960.7: Generic Equivalent Drug Law – Pennsylvania
Status: Enacted
Year Enacted: 1976
It is the purpose of this act to permit consumers to secure necessary drugs at the most economical cost consistent with the professional discretion of the purchaser’s physician and pharmacist.
Status: Enacted
Year Enacted: 2016
Governs PBM cost transparency requirements.
Status: Enacted
Year Enacted: 2000
Allows pharmacists to substitute generics. Must disclose price difference to consumer if they choose not to substitute.
Status: Enacted
Year Enacted: 2018
Provides regulation of pharmacy benefit managers, such as they may not prohibit a pharmacist or pharmacy from providing an insured individual information on the amount of the insured’s cost share for the insured’s prescription drug […]
Cal. Bus. & Prof. Code §§ 4050 through 4068: Pharmacy — Scope of Practice and Exemptions – California
Status: Enacted
Year Enacted: 1996
Notwithstanding any other law, a pharmacist may authorize the initiation of a prescription, pursuant to Section 4052.1, 4052.2, 4052.3, or 4052.6, and otherwise provide clinical advice, services, information, or patient consultation, as set forth in […]
Status: Enacted
Year Enacted: 2007
The State shall make information regarding prescription drugs available to the public, including but not limited to, ways in which the uninsured can access lower cost prescription drugs and contact information for lower cost programs.
Conn. Gen. Stat. § 20-14a. Prescription of drugs by generic name. Disclosure to patient. Labeling: Medicine and Surgery – Connecticut
Status: Enacted
Year Enacted: 1972
For the purposes of this section, “brand name” means the name the manufacturer places upon a drug or pharmaceutical or on its container, label, or wrapping at the time of packaging; and “generic name” means […]
D.C. Code § 31-3834.03. Coverage of additional preventive health services: Women’s Rights Regarding Certain Health Insurance – District of Columbia
Status: Enacted
Year Enacted: 2001
Health insurance coverage through Medicaid or the D.C. Healthcare Alliance program shall also provide additional coverage and shall not impose any cost-sharing requirements for these additional benefits.
D.C. Code § 48-831.12. Method of prescribing or ordering drugs: Affordability of Prescription Drugs- AccessRx Program – District of Columbia
Status: Enacted
Year Enacted: 2004
The method of prescribing or ordering drugs may include, but is not limited to, the use of standard or larger prescription refill sizes in order to minimize operational costs and maximize economy. Unless the prescribing […]
D.C. Code § 48-831.15. Annual summary report: Affordability of Prescription Drugs- AccessRx Program – District of Columbia
Status: Enacted
Year Enacted: 2004
The Department shall submit a written report on the enrollment and financial status of AccessRx to the Council by the 2nd week of January each year.
D.C. Code § 48-831.16. Agreements with governments of other jurisdictions and other entities: Affordability of Prescription Drugs- AccessRx Program – District of Columbia
Status: Enacted
Year Enacted: 2004
The District may negotiate and enter into purchasing alliances and regional strategies with the governments of other jurisdictions, and with other public and private entities, for the purpose of reducing prescription drug prices for residents […]
Status: Enacted
Year Enacted: 1980
A pharmacy benefit manager that reimburses a contracting pharmacy for a drug on a maximum allowable cost basis shall comply with the requirements of this section. (b) The pharmacy benefit manager shall include the following […]
Status: Enacted
Year Enacted: 1998
The State’s Medicaid managed care and fee-for-service programs shall not deny coverage for any service provided through telehealth that would be covered if the service were provided through in-person consultation between a patient and a […]
Status: Enacted
Year Enacted: 2016
A pharmacist who dispenses a biological product shall communicate to the prescriber the name and manufacturer of the drug within five business days following the dispensing of the biological product. Communication shall occur via an […]
Status: Enacted
Year Enacted: 1999
Statutes provide the benefit package of the children’s health insurance program and which services may require prior authorization. Statutes also outline premium and cost sharing requirements. The office shall require the use of generic drugs […]
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.